Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Annals of the College of Medicine-Mosul. 2003; 29 (1): 17-21
in English | IMEMR | ID: emr-205686

ABSTRACT

Context: Hyperlipidemia is frequently common in uremia and persists after successful renal transplantation [RT]. It is one of the risk factor for the development of atherosclerosis in RT recipient and has a deleterious effect on graft function


Objective: To assess the prevalence of hyperlipidemia in RT in Mosul and to determine its types


Design: Prospective study of hyperlipidemia in RT using clinical and laboratory investigation of their lipid profile, renal function, serum glucose, proteinuria and immunosuppressive therapy


Setting: The study was conducted in the out patient nephrology clinic at lbn Sina teaching hospital between June 2000 November 2001 who had RT


Participants: Seventy eight of RT patients, [44] males and [34] females, with a mean age of [38] years and age range of [11-55] years transplanted within a period of 3 months 17 years were included. Fifty apparently healthy subjects, [26] males and [24] females, of normolipidemic state were taken as a control group


Results: Different types of hyperlipidemia were detected. hypercholesterolemia in 58.9%, combined hyperlipidemia in 62.8%; i.e., increase in both total cholesterol [TC] and triglycerides [TG]. Higher total cholesterol, low-density lipoprotein cholesterol [LDL-C], very low-density lipoprotein [VLDL-C] and serum triglycerides were encountered in patients with RT less than one year compared with those with RT more than one year. Higher TC, VLDL-C, TG seen in chose receiving triple immunosuppressive therapy [cyclosporine. corticosteroid and azathioprino] than those on dual therapy [corticosteroid and azathioprine]. The effect of acute rejection on serum lipid variable of RT patients is well established. The causes and the explanation were discussed


Conclusion: Hyperliprdemia is prevalent after RT, further investigations are needed to determine whether graft losses and late graft failure can be prevented or ameliorated by treating hyperlipidemia

SELECTION OF CITATIONS
SEARCH DETAIL